An immunohistochemical analysis of epithelial-to-mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma.

An immunohistochemical analysis of epithelial-to-mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma. - An immunohistochemical analysis of epithelial to mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008737

Enrollment

Registered

2012-08-22

Start date

2012-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Form December 2006 to December 2010, histologically diagnosed pulmonary sarcomatoid carcinoma and adenocarcinoma in Kansai Medical University Takii Hospital and Hirakata Hospital, Japan.

Exclusion criteria

Exclusion criteria: (1)Patient who lacked adequate amount of histological specimen. (2)Patient who refused to participate of this study.

Design outcomes

Primary

Measure	Time frame
The level of expression and phosphorylation of epithelial-to-mesenchymal transition associating molecules.	—

Secondary

Measure	Time frame
Overall survival, Progression-free survival, Tumor responses of treatment.	—

Countries

Japan

Contacts

Public ContactTakeshi Tamaki

Kansai Medical University First department of internal medicine

tamakit@hirakata.kmu.ac.jp06-6992-1001

Outcome results